William Blair & Company’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-75	Closed	–	–	1647
2018 Q1	$0	Buy	+75	New	–	﹤0.01%	1619